XOMAP Q3 2024 Earnings — XOMA Corporation Revenue & Financial Results | Market Cap Arena

XOMAPXOMA Corporation

$311M

Q3 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$7M+767.1% YoY

Gross Profit

$7M100.0% margin

Operating Income

-$16M-217.3% margin

Net Income

-$17M-239.6% margin

EPS (Diluted)

$-1.59

QoQ Revenue Growth

-35.1%

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$9M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$223M

Total Liabilities

$139M

Stockholders' Equity

$85M

Cash & Equivalents

$142M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$7M	$830,000	+767.1%
Gross Profit	$7M	$805,000	+794.0%
Operating Income	-$16M	-$6M	-170.3%
Net Income	-$17M	-$6M	-213.0%